DFTX
Definium Therapeutics, Inc.
36.20$
-3.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 84.8% | 83.4% | 92.7% | 92.4% | 93.6% | 93.2% | 80.5% | 71.3% | 91.1% | 95.3% | 94.8% | 98.1% | |
| 83.2% | 80.1% | 91.6% | 90.7% | 92.3% | 90.6% | 30.1% | 12.6% | 8.4% | 58.6% | 65.4% | 58.9% | |
| 83.2% | 80.1% | 91.6% | 90.7% | 92.3% | 90.6% | 77.2% | 69.0% | 88.2% | 93.5% | 93.1% | 97.4% | |
| 14.1% | 16.0% | 7.2% | 7.4% | 6.2% | 6.6% | 7.2% | 7.5% | 8.4% | 4.5% | 5.0% | 1.8% | |
| 0.9% | 0.4% | – | – | 0.2% | – | – | – | – | – | – | – | |
| 32.2% | 37.3% | 28.8% | 24.7% | 18.0% | 20.1% | 19.1% | 30.1% | 44.9% | 24.5% | 30.5% | 17.5% | |
| 22.0% | 25.9% | 23.7% | 15.6% | 10.4% | 12.9% | 11.1% | 14.3% | 27.6% | 15.2% | 20.2% | 14.1% | |
| 5.4% | 3.3% | 2.8% | 1.1% | 0.7% | 0.7% | 0.8% | 1.6% | 3.4% | 1.2% | 1.8% | 0.6% | |
| – | – | – | – | 7.6% | 7.2% | 8.0% | 15.5% | 17.0% | 9.2% | 10.2% | 3.3% | |
| 67.8% | 62.7% | 71.2% | 75.3% | 82.0% | 79.9% | 80.9% | 69.9% | 55.1% | 75.5% | 69.5% | 82.5% | |
| -188.2% | -233.0% | -125.1% | -130.7% | -113.9% | -132.0% | -153.4% | -175.4% | -224.7% | -132.4% | -164.4% | -73.6% | |
| 28.1% | 32.3% | 17.4% | 26.8% | 25.1% | 27.8% | 31.6% | 32.2% | 36.3% | 20.3% | 27.1% | 9.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.